Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 318
Selected: 0
NCT IDTitle
NCT02648854Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers
NCT06838286Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
NCT04334213A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150
NCT03583905Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet
NCT05041790A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
NCT03762369A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
NCT03802162A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
NCT04521023A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
NCT03150316CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT05193565Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
NCT05834595A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828
NCT03017950Pharmacokinetic Drug-drug Interaction of CKD-330 and D086
NCT07198191SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT02811731Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B
NCT04667975The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
NCT04246190A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
NCT06110923A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
NCT02627027A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers
NCT02977065To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
NCT06044493MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
NCT02854748Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin
NCT06974903Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT03641352The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes
NCT04035538A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012
NCT06492655To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers
NCT06916793A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia
NCT03928470Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg
NCT02805738Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet
NCT03067415Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
NCT02358824CKD-828 (80/5mg) Pharmacokinetic Study
NCT01030679Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus
NCT03616392Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308
NCT04304547Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
NCT01819870Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg
NCT01356043CKD-828 Drug Interaction Study (S-amlodipine)
NCT01560325Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers
NCT01356017CKD-828 Drug Interaction Study (Telmisartan)
NCT03211143A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
NCT04260438Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects
NCT03437785Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet
NCT03431623CKD-11101 Phase 3 SC Study
NCT05347576A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
NCT03569579CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1)
NCT04673864A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386
NCT02300467NOV120401 (CKD-516 Tablet) for Advanced Solid Tumors
NCT04223895A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volunteers
NCT03794492Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
NCT06695598Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT01860482The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD
NCT04628143A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia